Prior evidence indicates that bile acids promote tumor proliferation and angiogenesis via FXR-dependent mechanisms (30, 31) while suppressing natural killer (NK) cell activity and recruiting regulatory T cells (Tregs) to foster an immunosuppressive niche (32, 33). The gene discussed is NR1H4; the disease is neoplasm.